The interplay between cellular plasticity and stemness factors like OCT4, SOX2, and NANOG enables PCa cells to adapt under therapeutic pressure, contributing to tumor heterogeneity, EMT activation, and drug resistance [132]. Here, POU5F1 is linked to neoplasm.